Updates on cardiovascular outcome trials in diabetes. - Wikidata - wikimedia - TriplyDB

Updates on cardiovascular outcome trials in diabetes.

Updates on cardiovascular outcome trials in diabetes.

http://www.wikidata.org/entity/Q42375211

about

Correction to: Updates on cardiovascular outcome trials in diabetes.Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.Unexplained reciprocal regulation of diabetes and lipoproteins.Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials.Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study

P2860

Q47131136-902C8DCE-654F-4B26-AC6E-AA19F4B8E6E1 Q49843638-0D5F0F07-720A-4393-A244-9EB3975B998B Q49920839-1DA49F33-525F-4941-88F9-188740601441 Q53690107-45D81865-E177-4643-AB60-E0F2BF5CB431 Q55207460-E9B5065F-E51C-4D20-AABB-FD96B1686F32 Q55235411-3639C212-575C-4B96-9967-C045424A2AD5 Q58767469-7520DCD0-B02E-4A40-A9C7-BC96CFA6A44C

P2860

Updates on cardiovascular outcome trials in diabetes.

http://www.wikidata.org/entity/Q42375211

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Updates on cardiovascular outcome trials in diabetes.

@en

Updates on cardiovascular outcome trials in diabetes.

@nl

type

label

Updates on cardiovascular outcome trials in diabetes.

@en

Updates on cardiovascular outcome trials in diabetes.

@nl

prefLabel

Updates on cardiovascular outcome trials in diabetes.

@en

Updates on cardiovascular outcome trials in diabetes.

@nl

P1433

Q42375211-43D0FFFC-2B38-413F-B360-F5D44F19E154

P1476

Q42375211-AAB88C6D-0FFD-4A08-8CBC-E86A1B074413

P2093

Q42375211-1EBCAB21-793B-4DBF-8B5D-0B9ADF1DD143

Q42375211-2024597C-F84E-4F57-B48C-2193DF16117C

Q42375211-3376964C-BEBF-4F71-923E-D6D703E58C84

Q42375211-9CF65922-1E81-4DE0-967E-4E237FA32A34

Q42375211-A174E53D-80F5-4D28-A038-67F07E4FDCA5

P275

Q42375211-0696509D-5F29-419E-A173-8B2F10B5D340

P2860

Q42375211-0936A6FC-FF69-47A1-85A4-07E74A60DC0C

Q42375211-0FE87B87-D30D-449C-99F0-667E69A1C877

Q42375211-16010982-F2D6-44B0-8B8E-8E30BD3AF88E

Q42375211-1C658D95-F2BB-4A4F-8B93-BD788B9D6074

Q42375211-22F6BCFD-6C5F-4660-85D9-E60A4DFDE0C0

Q42375211-239A1B53-5A37-40CF-B7A3-4899958BF006

Q42375211-31F0FA34-6187-4867-9BE9-64941EEFDE28

Q42375211-329CD6D6-E627-452C-8B9E-EA824B4EA421

Q42375211-3313E010-52C7-49A2-85BC-5F0579728E5A

Q42375211-411975B4-E3E2-4D00-A987-C6B6D198209D

P2888

Q42375211-8D6FA69E-6E03-40E7-BBA9-E7BD35FF39B1

P304

Q42375211-54C96A5D-22B2-4F62-9BB3-0BC9C8B88CB4

P31

Q42375211-1A42DCD5-F225-4EF1-948D-7F1C41DBD94E

Q42375211-2226580C-6556-4E88-AB39-1C3FE9BA23ED

P356

Q42375211-54B4B157-8209-4B02-9F4E-684DC494DA1B

P407

Q42375211-B4335259-5347-47DB-810E-1901F5B5997E

P433

Q42375211-3B1BA738-78EB-43E2-95E7-6534EF041D52

P478

Q42375211-C9E106D0-F268-4477-B5A0-1A729F8A67F3

P5008

Q42375211-70A94AD1-4791-4588-A664-D39298F26C47

P577

Q42375211-019868CA-C02C-4BB5-BB59-44CAD9AAA804

P6179

Q42375211-A5BDB52E-DF92-4993-B55C-709485ECBBAE

P698

Q42375211-EBB9935D-9092-41EC-9BF3-4AC46C1EA544

P921

Q42375211-03DBCD9E-32C9-48F3-A090-BA92478E2E91

Q42375211-08DABE08-72E3-47F0-838D-784AF9C7113B

Q42375211-46334AF1-7FF2-4DEB-A167-F425BABF18F4

Q42375211-896CE8CE-E3A1-46FF-AF8B-912CF2985C6B

Q42375211-977AEEA8-3852-48DC-9D5A-B6FF40E6A64F

Q42375211-CC0F87A9-0766-4644-88FF-1CBB47293E27

Q42375211-E6DCF0DE-AFED-4E14-A55D-EA0E98883866

P932

Q42375211-A79429AA-0E1B-47FA-9459-85BF153B85A7

P356

S12933-017-0610-Y

P1433

Cardiovascular Diabetology

P1476

Updates on cardiovascular outcome trials in diabetes.

@en

P2093

Antonio Ceriello

http://www.w3.org/2001/XMLSchema#string

D&CVD EASD Study Group

http://www.w3.org/2001/XMLSchema#string

Eberhard Standl

http://www.w3.org/2001/XMLSchema#string

Lars Rydén

http://www.w3.org/2001/XMLSchema#string

Oliver Schnell

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Current perspectives on cardiovascular outcome trials in diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

P2888

s12933-017-0610-y

P304

128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0610-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092173565

http://www.w3.org/2001/XMLSchema#string

P698

29020969

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

type-2 diabetes

mechanism of action

cardiovascular disease

membrane proteins

maturity-onset diabetes of the young

biomedical investigative technique

P932

5637292

http://www.w3.org/2001/XMLSchema#string